0001665329-16-000003.txt : 20161005
0001665329-16-000003.hdr.sgml : 20161005
20161005113647
ACCESSION NUMBER: 0001665329-16-000003
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20161005
DATE AS OF CHANGE: 20161005
EFFECTIVENESS DATE: 20161005
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MTS Health Investors IV, L.P.
CENTRAL INDEX KEY: 0001665329
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-258278
FILM NUMBER: 161921683
BUSINESS ADDRESS:
STREET 1: 623 FIFTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-887-2100
MAIL ADDRESS:
STREET 1: 623 FIFTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001665329
MTS Health Investors IV, L.P.
623 FIFTH AVENUE, 16TH FLOOR
NEW YORK
NY
NEW YORK
10022
212-887-2100
DELAWARE
None
None
Limited Partnership
true
2015
Curtis
S.
Lane
c/o MTS Health Investors
623 Fifth Avenue, 16th Floor
New York
NY
NEW YORK
10022
Executive Officer
Oliver
T.
Moses
c/o MTS Health Investors
623 Fifth Avenue, 16th Floor
New York
NY
NEW YORK
10022
Executive Officer
Alexander
Buzik
c/o MTS Health Investors
623 Fifth Avenue, 16th Floor
New York
NY
NEW YORK
10022
Executive Officer
Pooled Investment Fund
Private Equity Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
true
0001665329-16-000002
2016-02-12
false
true
true
false
0
Probitas Funds Group, LLC
115876
None
None
425 California Street
Suite 2300
San Francisco
CA
CALIFORNIA
94104
CA
CALIFORNIA
CT
CONNECTICUT
FL
FLORIDA
IL
ILLINOIS
LA
LOUISIANA
MS
MISSISSIPPI
NY
NEW YORK
NC
NORTH CAROLINA
ND
NORTH DAKOTA
OH
OHIO
PA
PENNSYLVANIA
TX
TEXAS
UT
UTAH
VT
VERMONT
VA
VIRGINIA
false
350000000
350000000
0
The general partner reserves the right to offer a greater or lesser amount of limited partner interests.
false
52
2819400
0
0
true
The general partner is entitled to a performance allocation. The investment manager is entitled to a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials.
false
MTS Health Investors IV, L.P.
Curtis S. Lane
Curtis S. Lane
Senior Managing Director
2016-09-30